Summary of Stock Option Activity (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Stock-based Compensation | |||
| Shares Underlying Options, Beginning balance | 628 | ||
| Weighted Average Exercise Price, Beginning Balance | $ 6,874.80 | ||
| Weighted Average Remaining Contractual Term (in years), Outstanding | 8 years 4 months 24 days | 8 years 7 months 20 days | 8 years 6 months 7 days |
| Intrinsic Value Outstanding, Beginning Balance | |||
| Shares Underlying Options, Forfeited | 3 | ||
| Weighted Average Exercise Price, Forfeited | $ 1,170.00 | $ 34,009.40 | |
| Shares Underlying Options, Ending balance | 628 | 628 | |
| Weighted Average Exercise Price, Ending Balance | $ 6,901.20 | $ 6,874.80 | |
| Intrinsic Value Outstanding, Ending Balance | |||
| Shares Underlying Options, Exercisable | 203 | 196 | |
| Weighted Average Exercise Price, Exercisable | $ 12,959.60 | $ 12,206.99 | |
| Weighted Average Remaining Contractual Term (in years), Exercisable | 7 years 10 months 24 days | 8 years 1 month 24 days | |
| Intrinsic Value Outstanding, Exercisable | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|